Showing results (221-230 of 453) with videos related to

Sort By:
Pageof 46
Journal of Clinical Pharmacology|November 28, 2017
The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy VolunteersKarthick Vishwanathan, Paul A Dickinson, Khanh Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2015
Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical TrialsSaeed Rafii, Desamparados Roda, Elena Geuna, et al.
Gynecologic Oncology|June 15, 2020
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tractMichael Frumovitz, Shannon N Westin, Gloria Salvo, et al.
Cancer Chemotherapy and Pharmacology|August 9, 2018
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumorsMary E R O'Brien, Debashis Sarker, Jaishree Bhosle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid TumorsTimothy A Yap, Anthony W Tolcher, Ruth Plummer, et al.
Frontiers in Microbiology|December 2, 2022
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animalsCarla Usai, Lola Pailler-García, Cristina Lorca-Oró, et al.
The Oncologist|March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignanciesJibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?Marta Capelan, Desamparados Roda, Elena Geuna, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumoursLaura Vidal, Ivan Victoria, Lydia Gaba, et al.
Antiviral Research|March 1, 2022
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysisMartin Sachse, Raquel Tenorio, Isabel Fernández de Castro, et al.
Pageof 46